By-Health
By-Health Co. produces and sells nutritional and dietary supplements primarily in China.
Launch date
Employees
Market cap
$2.5b
Enterprise valuation
$2.1b (Public information from Sep 2024)
Share price
CNY11.03 300146.SZ
Guangzhou Guangdong (HQ)
Financials
Estimates*
| CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 6.1b | 7.4b | 7.9b | 9.4b | 8.3b | 9.3b | 10.2b |
| % growth | 16 % | 22 % | 6 % | 20 % | (12 %) | 12 % | 9 % |
| EBITDA | 1.8b | 2.4b | 2.2b | 2.4b | 1.5b | 1.9b | 2.2b |
| % EBITDA margin | 29 % | 32 % | 28 % | 26 % | 18 % | 20 % | 22 % |
| Profit | 1.5b | 1.8b | 1.4b | 1.7b | 1.2b | 1.5b | 1.7b |
| % profit margin | 25 % | 24 % | 18 % | 19 % | 14 % | 16 % | 17 % |
| EV / revenue | 6.0x | 5.8x | 4.6x | 3.1x | 2.0x | 1.8x | 1.6x |
| EV / EBITDA | 20.9x | 17.8x | 16.6x | 12.0x | 11.4x | 9.2x | 7.5x |
| R&D budget | 140m | 150m | 158m | 179m | - | - | - |
| R&D % of revenue | 2 % | 2 % | 2 % | 2 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
